Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
http://academic.oup.com/jnci/article-pdf/97/16/1180/7686400/dji237.pdf
Reference42 articles.
1. Hayes DF, Bast RC, Desch CE, Fritsche H Jr, Kemeny NE, Jessup JM, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst1996 ; 88 : 1456 –66.
2. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, et al. for the American Society of Clinical Oncology Tumor Markers Expert Panel. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol2001 ; 19 : 1865 –78.
3. Schilsky RL and Taube SE. Introduction: Tumor markers as clinical cancer tests—are we there yet? Semin Oncol2002 ; 29 : 211 –2.
4. McGuire WL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst1991 ; 83 : 154 –5.
5. Fielding LP, Fenoglio-Preiser CM, and Freedman LS. The future of prognostic factors in outcome prediction for patients with cancer. Cancer1992 ; 70 : 2367 –77.
Cited by 1264 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The FSCN1 gene rs2966447 variant is associated with increased serum fascin-1 levels and breast cancer susceptibility;Gene;2024-11
2. Preoperative level of serum transthyretin as a novel biomarker predicting survival in resected pancreatic ductal adenocarcinoma with neoadjuvant therapy;Pancreatology;2024-09
3. Blood Biomarkers of Long COVID: A Systematic Review;Molecular Diagnosis & Therapy;2024-08-05
4. Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial;iScience;2024-08
5. Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression;European Urology Open Science;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3